Ken Griffin Sera Prognostics, Inc. Call Options Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
Call Options
2 transactions
Others Institutions Holding SERA
# of Institutions
76Shares Held
20.3MCall Options Held
28.9KPut Options Held
36.8K-
Baker Bros. Advisors LP New York, NY5.43MShares$22.2 Million0.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$12.4 Million0.43% of portfolio
-
Interwest Venture Management CO2.42MShares$9.88 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$6.75 Million2.79% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$5.77 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $121M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...